Skip to main content

CalciMedica, Inc.

CALC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001534133

No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding CalciMedica, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of CALC: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders013+13
Shares0678.6K+678.6K
Value$0$2.72M+$2.72M

New holders (13)

Institutions that held CalciMedica, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to CALC in Q2 2023
InstitutionSharesValue% of portfolio
OrbiMed Advisors LLC297,380$1.19M0.02%
Deerfield Management Company, L.P. (Series C)265,657$1.07M0.02%
BML Capital Management, LLC88,781$356.0K0.32%
First Manhattan Co13,226$53.0K0.00%
Meritage Portfolio Management10,000$40.0K0.00%
Tower Research Capital LLC (TRC)1,882$7.55K0.00%
Morgan Stanley1,556$6.24K0.00%
GWM Advisors LLC71$2850.00%
Wells Fargo & Company14$560.00%
UBS Group AG14$560.00%
Gradient Investments LLC13$520.00%
Bank of America Corp1$40.00%
Cutler Group LP14$00.00%

Sold out (0)

Institutions that held CalciMedica, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

None.